Orthodontically Relevant Manifestations in People with Rare Diseases.

Interdisciplinary dentistry Oral medicine Orofacial manifestations Orthodontics Rare diseases

Journal

Medical principles and practice : international journal of the Kuwait University, Health Science Centre
ISSN: 1423-0151
Titre abrégé: Med Princ Pract
Pays: Switzerland
ID NLM: 8901334

Informations de publication

Date de publication:
2019
Historique:
received: 22 07 2018
accepted: 04 02 2019
pubmed: 5 2 2019
medline: 18 6 2020
entrez: 5 2 2019
Statut: ppublish

Résumé

Approximately 15% of all rare diseases occur with orofacial manifestations. Symptoms and manifestations of relevance to orthodontists represent a considerable proportion of these diseases and require appropriate strategies for their treatment. This article provides an overview of the orthodontically relevant manifestations of rare diseases. Overall, 3,639 rare diseases listed at the Orphanet, OMIM or Pubmed database were evaluated for orofacial manifestations. All rare diseases which were indicated with at least one orofacial manifestation were recorded in a database for rare diseases with orofacial manifestations called "ROMSE," which was developed by the authors. All the rare diseases were analysed with regard to orthodontically relevant orofacial manifestations, such as dysgnathia, changes in the number of teeth, failures of eruption, pathologies of bone metabolism or orofacial clefts. For all rare diseases with orthodontic relevance, an exact analysis was undertaken. The orthodontically relevant orofacial manifestation termed dysgnathia is described in 151 of 535 identified rare diseases (28.2%). In these 151 rare diseases, 15 different subforms of dysgnathia, in the sense of skeletal misdevelopments of the jaws but without dental abnormalities, were described. Also changes in the number of teeth (17.9%), orofacial clefts (27.6%), failures of eruption (8.4%) and pathologies of the bone (2.1%) were described. Orthodontics play an important role in the diagnosis and treatment of orofacial manifestations in rare diseases. Databases such as ROMSE are a first step toward providing valid information in publicly accessible databases.

Sections du résumé

BACKGROUND
Approximately 15% of all rare diseases occur with orofacial manifestations. Symptoms and manifestations of relevance to orthodontists represent a considerable proportion of these diseases and require appropriate strategies for their treatment. This article provides an overview of the orthodontically relevant manifestations of rare diseases.
MATERIAL AND METHODS
Overall, 3,639 rare diseases listed at the Orphanet, OMIM or Pubmed database were evaluated for orofacial manifestations. All rare diseases which were indicated with at least one orofacial manifestation were recorded in a database for rare diseases with orofacial manifestations called "ROMSE," which was developed by the authors. All the rare diseases were analysed with regard to orthodontically relevant orofacial manifestations, such as dysgnathia, changes in the number of teeth, failures of eruption, pathologies of bone metabolism or orofacial clefts. For all rare diseases with orthodontic relevance, an exact analysis was undertaken.
RESULTS
The orthodontically relevant orofacial manifestation termed dysgnathia is described in 151 of 535 identified rare diseases (28.2%). In these 151 rare diseases, 15 different subforms of dysgnathia, in the sense of skeletal misdevelopments of the jaws but without dental abnormalities, were described. Also changes in the number of teeth (17.9%), orofacial clefts (27.6%), failures of eruption (8.4%) and pathologies of the bone (2.1%) were described.
CONCLUSIONS
Orthodontics play an important role in the diagnosis and treatment of orofacial manifestations in rare diseases. Databases such as ROMSE are a first step toward providing valid information in publicly accessible databases.

Identifiants

pubmed: 30716736
pii: 000497437
doi: 10.1159/000497437
pmc: PMC6597940
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

216-221

Informations de copyright

© 2019 The Author(s) Published by S. Karger AG, Basel.

Références

Clin Genet. 2017 Nov;92(5):477-486
pubmed: 28105635
Int J Environ Res Public Health. 2018 Jul 15;15(7):
pubmed: 30011949
BMC Oral Health. 2016 Aug 02;17(1):33
pubmed: 27485511
Internist (Berl). 2018 Sep;59(9):972-980
pubmed: 29974133
J Med Internet Res. 2017 Jan 18;19(1):e23
pubmed: 28100442
Orphanet J Rare Dis. 2017 Aug 7;12(1):137
pubmed: 28784158
Med Princ Pract. 2017;26(1):61-65
pubmed: 27721313
Internist (Berl). 2018 Apr;59(4):391-400
pubmed: 28364276
Aust Orthod J. 2014 Nov;30(2):214-20
pubmed: 25549525
Med Princ Pract. 2015;24(4):362-8
pubmed: 26045154
Br J Oral Maxillofac Surg. 2017 Jun;55(5):500-503
pubmed: 28238524

Auteurs

Marcel Hanisch (M)

Research Unit Rare Diseases with Orofacial Manifestations (RDOM), Department of Cranio-Maxillofacial Surgery, University Hospital Münster, Münster, Germany, marcel.hanisch@ukmuenster.de.
Department of Oral Surgery and Dental Emergency Care, School of Dentistry, Faculty of Health, Witten/Herdecke University, Witten, Germany, marcel.hanisch@ukmuenster.de.

Lale Hanisch (L)

Department of Orthodontics, School of Dentistry, Faculty of Health, Witten/Herdecke University, Witten, Germany.

Johannes Kleinheinz (J)

Research Unit Rare Diseases with Orofacial Manifestations (RDOM), Department of Cranio-Maxillofacial Surgery, University Hospital Münster, Münster, Germany.

Gholamreza Danesh (G)

Department of Orthodontics, School of Dentistry, Faculty of Health, Witten/Herdecke University, Witten, Germany.

Korbinian Benz (K)

Department of Oral Surgery and Dental Emergency Care, School of Dentistry, Faculty of Health, Witten/Herdecke University, Witten, Germany.

Joachim Jackowski (J)

Department of Oral Surgery and Dental Emergency Care, School of Dentistry, Faculty of Health, Witten/Herdecke University, Witten, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH